Copley Scientific has announced the launch of its SRS 100i automated sample recovery system for use with delivered dose uniformity and APSD testing set-ups, including the compendial dose uniformity sample apparatus (DUSA), the Next Generation Impactor (NGI), and the Andersen Cascade Impactor. The company says the SRS 100i “seamlessly integrates with the company’s Inhalytix®+ software to enable unified, audit-ready workflows” and performs component loading, solvent dispensation, dissolution, and collection of samples.
Earlier this year, Copley introduced its new Inhaled Dissolution Apparatus (IDA) for dissolution testing of OINDPs. In 2025, the company’s innovations included the PTW Powder Testing Workstation for flowability testing and the PTA100i Powder Testing Assistant.
Copley Head of Business Development Paul Martin commented, “The SRS 100i is a key step forward in reducing one of the most variable and operator-dependent aspects of inhaler testing. By introducing a controlled and standardized approach to drug recovery, it helps laboratories improve consistency, strengthen data integrity and generate results that are more robust and defensible across analysts and sites. As part of our wider focus on connected, automated workflows, the SRS 100i supports a shift towards a more efficient, traceable and reproducible inhaler testing process”.
Read the Copley Scientific press release
